NCT00192361View on ClinicalTrials.gov

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 1999

Conditions
Influenza
Interventions
BIOLOGICAL

CAIV-T

Trial Locations (1)

33101

Kauppakatu Clinic, Tampere

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY

NCT00192361 - Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0) | Biotech Hunter | Biotech Hunter